Global Active Collagen Peptide Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Active Collagen Peptide Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Active Collagen Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Animal Source
  • 1.2.3 Recombinant Human Source
• 1.3 Market by Application
  • 1.3.1 Global Active Collagen Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Pharmaceuticals
  • 1.3.3 Medical Beauty and Skin Management
  • 1.3.4 Functional Foods
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Active Collagen Peptide Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Active Collagen Peptide Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Active Collagen Peptide Revenue by Region (2020-2031)
  • 2.2.3 Global Active Collagen Peptide Revenue Market Share by Region (2020-2031)
• 2.3 Global Active Collagen Peptide Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Active Collagen Peptide Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Active Collagen Peptide Sales by Region (2020-2031)
  • 2.4.3 Global Active Collagen Peptide Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Active Collagen Peptide Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Active Collagen Peptide Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Collagen Peptide in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Active Collagen Peptide Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Active Collagen Peptide Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Active Collagen Peptide Revenue in 2024
• 3.3 Global Key Players of Active Collagen Peptide, Industry Ranking, 2023 VS 2024
• 3.4 Global Active Collagen Peptide Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Active Collagen Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Active Collagen Peptide, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Active Collagen Peptide, Product Offered and Application
• 3.8 Global Key Manufacturers of Active Collagen Peptide, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Active Collagen Peptide Historical Sales by Type (2020-2025)
  • 4.1.2 Global Active Collagen Peptide Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Active Collagen Peptide Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Active Collagen Peptide Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Active Collagen Peptide Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Active Collagen Peptide Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Active Collagen Peptide Price by Type (2020-2025)
  • 4.3.2 Global Active Collagen Peptide Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Active Collagen Peptide Historical Sales by Application (2020-2025)
  • 5.1.2 Global Active Collagen Peptide Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Active Collagen Peptide Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Active Collagen Peptide Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Active Collagen Peptide Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Active Collagen Peptide Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Active Collagen Peptide Price by Application (2020-2025)
  • 5.3.2 Global Active Collagen Peptide Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Active Collagen Peptide Sales by Type (2020-2031)
  • 6.1.2 US & Canada Active Collagen Peptide Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Active Collagen Peptide Sales by Application (2020-2031)
  • 6.2.2 US & Canada Active Collagen Peptide Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Active Collagen Peptide Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Active Collagen Peptide Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Active Collagen Peptide Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Active Collagen Peptide Sales by Type (2020-2031)
  • 7.1.2 Europe Active Collagen Peptide Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Active Collagen Peptide Sales by Application (2020-2031)
  • 7.2.2 Europe Active Collagen Peptide Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Active Collagen Peptide Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Active Collagen Peptide Sales by Country (2020-2031)
  • 7.3.3 Europe Active Collagen Peptide Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Active Collagen Peptide Sales by Type (2020-2031)
  • 8.1.2 China Active Collagen Peptide Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Active Collagen Peptide Sales by Application (2020-2031)
  • 8.2.2 China Active Collagen Peptide Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Active Collagen Peptide Sales by Type (2020-2031)
  • 9.1.2 Asia Active Collagen Peptide Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Active Collagen Peptide Sales by Application (2020-2031)
  • 9.2.2 Asia Active Collagen Peptide Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Active Collagen Peptide Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Active Collagen Peptide Revenue by Region (2020-2031)
  • 9.3.3 Asia Active Collagen Peptide Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Active Collagen Peptide Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Active Collagen Peptide Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Active Collagen Peptide Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Active Collagen Peptide Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Active Collagen Peptide Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Active Collagen Peptide Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Active Collagen Peptide Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Meiji
  • 11.1.1 Meiji Company Information
  • 11.1.2 Meiji Overview
  • 11.1.3 Meiji Active Collagen Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Meiji Active Collagen Peptide Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Meiji Recent Developments
• 11.2 PB Leiner
  • 11.2.1 PB Leiner Company Information
  • 11.2.2 PB Leiner Overview
  • 11.2.3 PB Leiner Active Collagen Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 PB Leiner Active Collagen Peptide Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 PB Leiner Recent Developments
• 11.3 GELITA
  • 11.3.1 GELITA Company Information
  • 11.3.2 GELITA Overview
  • 11.3.3 GELITA Active Collagen Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 GELITA Active Collagen Peptide Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 GELITA Recent Developments
• 11.4 Amicogen
  • 11.4.1 Amicogen Company Information
  • 11.4.2 Amicogen Overview
  • 11.4.3 Amicogen Active Collagen Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Amicogen Active Collagen Peptide Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Amicogen Recent Developments
• 11.5 Rousselot
  • 11.5.1 Rousselot Company Information
  • 11.5.2 Rousselot Overview
  • 11.5.3 Rousselot Active Collagen Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 Rousselot Active Collagen Peptide Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Rousselot Recent Developments
• 11.6 Hubei Reborn Biological Technology
  • 11.6.1 Hubei Reborn Biological Technology Company Information
  • 11.6.2 Hubei Reborn Biological Technology Overview
  • 11.6.3 Hubei Reborn Biological Technology Active Collagen Peptide Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 Hubei Reborn Biological Technology Active Collagen Peptide Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Hubei Reborn Biological Technology Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Active Collagen Peptide Industry Chain Analysis
• 12.2 Active Collagen Peptide Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Active Collagen Peptide Production Mode & Process
• 12.4 Active Collagen Peptide Sales and Marketing
  • 12.4.1 Active Collagen Peptide Sales Channels
  • 12.4.2 Active Collagen Peptide Distributors
• 12.5 Active Collagen Peptide Customers

13 Active Collagen Peptide Market Dynamics

• 13.1 Active Collagen Peptide Industry Trends
• 13.2 Active Collagen Peptide Market Drivers
• 13.3 Active Collagen Peptide Market Challenges
• 13.4 Active Collagen Peptide Market Restraints

14 Key Findings in the Global Active Collagen Peptide Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Active Collagen Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of Animal Source

Table 3. Major Manufacturers of Recombinant Human Source

Table 4. Global Active Collagen Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 5. Global Active Collagen Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Revenue Market Share by Region (2020-2031)

Table 8. Global Active Collagen Peptide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 9. Global Active Collagen Peptide Sales by Region (2020-2031) & (K Units)

Table 10. Global Sales Market Share by Region (2020-2031)

Table 11. Global Active Collagen Peptide Sales by Manufacturers (2020-2025) & (K Units)

Table 12. Global Active Collagen Peptide Sales Share by Manufacturers (2020-2025)

Table 13. Global Active Collagen Peptide Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 14. Global Active Collagen Peptide Revenue Market Share by Manufacturers (2020-2025)

Table 15. Global Key Players of Active Collagen Peptide, Industry Ranking, 2023 VS 2024 VS 2024

Table 16. Active Collagen Peptide Price by Manufacturers (2020-2025) & (US$/Unit)

Table 17. Global Active Collagen Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 18. Global Active Collagen Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Collagen Peptide as of 2024)

Table 19. Global Key Manufacturers of Active Collagen Peptide, Manufacturing Base Distribution and Headquarters

Table 20. Global Key Manufacturers of Active Collagen Peptide, Product Offered and Application

Table 21. Global Key Manufacturers of Active Collagen Peptide, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Active Collagen Peptide Sales by Type (2020-2025) & (K Units)

Table 24. Global Active Collagen Peptide Sales by Type (2026-2031) & (K Units)

Table 25. Global Sales Share by Type (2020-2031)

Table 26. Global Active Collagen Peptide Revenue by Type (2020-2025) & (US$ Million)

Table 27. Global Active Collagen Peptide Revenue by Type (2026-2031) & (US$ Million)

Table 28. Global Revenue Share by Type (2020-2031)

Table 29. Active Collagen Peptide Price by Type (2020-2025) & (US$/Unit)

Table 30. Global Active Collagen Peptide Price Forecast by Type (2026-2031) & (US$/Unit)

Table 31. Global Active Collagen Peptide Sales by Application (2020-2025) & (K Units)

Table 32. Global Active Collagen Peptide Sales by Application (2026-2031) & (K Units)

Table 33. Global Sales Share by Application (2020-2031)

Table 34. Global Active Collagen Peptide Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Active Collagen Peptide Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Revenue Share by Application (2020-2031)

Table 37. Active Collagen Peptide Price by Application (2020-2025) & (US$/Unit)

Table 38. Global Active Collagen Peptide Price Forecast by Application (2026-2031) & (US$/Unit)

Table 39. US & Canada Sales by Type (2020-2031) & (K Units)

Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 41. US & Canada Sales by Application (2020-2031) & (K Units)

Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 43. US & Canada Active Collagen Peptide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 45. US & Canada Sales by Country (2020-2031) & (K Units)

Table 46. Europe Sales by Type (2020-2031) & (K Units)

Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 48. Europe Sales by Application (2020-2031) & (K Units)

Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 50. Europe Active Collagen Peptide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 51. Europe Sales by Country (2020-2031) & (K Units)

Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 53. China Sales by Type (2020-2031) & (K Units)

Table 54. China Revenue by Type (2020-2031) & (US$ Million)

Table 55. China Sales by Application (2020-2031) & (K Units)

Table 56. China Revenue by Application (2020-2031) & (US$ Million)

Table 57. Asia Sales by Type (2020-2031) & (K Units)

Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 59. Asia Sales by Application (2020-2031) & (K Units)

Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 61. Asia Active Collagen Peptide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 63. Asia Sales by Region (2020-2031) & (K Units)

Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Active Collagen Peptide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 71. Meiji Company Information

Table 72. Meiji Description and Major Businesses

Table 73. Meiji Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 74. Meiji Product Model Numbers, Pictures, Descriptions and Specifications

Table 75. Meiji Recent Developments

Table 76. PB Leiner Company Information

Table 77. PB Leiner Description and Major Businesses

Table 78. PB Leiner Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 79. PB Leiner Product Model Numbers, Pictures, Descriptions and Specifications

Table 80. PB Leiner Recent Developments

Table 81. GELITA Company Information

Table 82. GELITA Description and Major Businesses

Table 83. GELITA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 84. GELITA Product Model Numbers, Pictures, Descriptions and Specifications

Table 85. GELITA Recent Developments

Table 86. Amicogen Company Information

Table 87. Amicogen Description and Major Businesses

Table 88. Amicogen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 89. Amicogen Product Model Numbers, Pictures, Descriptions and Specifications

Table 90. Amicogen Recent Developments

Table 91. Rousselot Company Information

Table 92. Rousselot Description and Major Businesses

Table 93. Rousselot Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 94. Rousselot Product Model Numbers, Pictures, Descriptions and Specifications

Table 95. Rousselot Recent Developments

Table 96. Hubei Reborn Biological Technology Company Information

Table 97. Hubei Reborn Biological Technology Description and Major Businesses

Table 98. Hubei Reborn Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Hubei Reborn Biological Technology Product Model Numbers, Pictures, Descriptions and Specifications

Table 100. Hubei Reborn Biological Technology Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. Distributors List

Table 104. Customers List

Table 105. Market Trends

Table 106. Market Drivers

Table 107. Market Challenges

Table 108. Market Restraints

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Active Collagen Peptide Product Picture

Figure 2. Global Active Collagen Peptide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Active Collagen Peptide Market Share by Type: 2024 & 2031

Figure 4. Animal Source Product Picture

Figure 5. Recombinant Human Source Product Picture

Figure 6. Global Active Collagen Peptide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Active Collagen Peptide Market Share by Application: 2024 & 2031

Figure 8. Pharmaceuticals

Figure 9. Medical Beauty and Skin Management

Figure 10. Functional Foods

Figure 11. Active Collagen Peptide Report Years Considered

Figure 12. Global Active Collagen Peptide Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 14. Global Active Collagen Peptide Revenue by Region (2020-2031) (US$ Million)

Figure 15. Global Active Collagen Peptide Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 16. Global Active Collagen Peptide Revenue Market Share by Region (2020-2031)

Figure 17. Global Active Collagen Peptide Sales (2020-2031) & (K Units)

Figure 18. Global Active Collagen Peptide Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 19. Global Active Collagen Peptide Sales Market Share by Region (2020-2031)

Figure 20. US & Canada Active Collagen Peptide Sales YoY (2020-2031) & (K Units)

Figure 21. US & Canada Active Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)

Figure 22. Europe Active Collagen Peptide Sales YoY (2020-2031) & (K Units)

Figure 23. Europe Active Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)

Figure 24. China Active Collagen Peptide Sales YoY (2020-2031) & (K Units)

Figure 25. China Active Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)

Figure 26. Asia (excluding China) Active Collagen Peptide Sales YoY (2020-2031) & (K Units)

Figure 27. Asia (excluding China) Active Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Active Collagen Peptide Sales YoY (2020-2031) & (K Units)

Figure 29. Middle East, Africa and Latin America Active Collagen Peptide Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Global Active Collagen Peptide Sales Share by Manufacturers (2024)

Figure 31. The Active Collagen Peptide Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 32. Global Active Collagen Peptide Revenue Share by Manufacturers (2024)

Figure 33. The Top 5 and 10 Largest Manufacturers of Active Collagen Peptide in the World: Market Share by Active Collagen Peptide Revenue in 2024

Figure 34. Global Active Collagen Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. Global Active Collagen Peptide Sales Market Share by Type (2020-2031)

Figure 36. Global Active Collagen Peptide Revenue Market Share by Type (2020-2031)

Figure 37. Global Active Collagen Peptide Sales Market Share by Application (2020-2031)

Figure 38. Global Active Collagen Peptide Revenue Market Share by Application (2020-2031)

Figure 39. US & Canada Active Collagen Peptide Sales Market Share by Type (2020-2031)

Figure 40. US & Canada Active Collagen Peptide Revenue Market Share by Type (2020-2031)

Figure 41. US & Canada Active Collagen Peptide Sales Market Share by Application (2020-2031)

Figure 42. US & Canada Active Collagen Peptide Revenue Market Share by Application (2020-2031)

Figure 43. US & Canada Active Collagen Peptide Revenue Share by Country (2020-2031)

Figure 44. US & Canada Active Collagen Peptide Sales Share by Country (2020-2031)

Figure 45. US Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Active Collagen Peptide Sales Market Share by Type (2020-2031)

Figure 48. Europe Active Collagen Peptide Revenue Market Share by Type (2020-2031)

Figure 49. Europe Active Collagen Peptide Sales Market Share by Application (2020-2031)

Figure 50. Europe Active Collagen Peptide Revenue Market Share by Application (2020-2031)

Figure 51. Europe Active Collagen Peptide Sales Share by Country (2020-2031)

Figure 52. Europe Active Collagen Peptide Revenue Share by Country (2020-2031)

Figure 53. Germany Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 54. France Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 58. China Active Collagen Peptide Sales Market Share by Type (2020-2031)

Figure 59. China Active Collagen Peptide Revenue Market Share by Type (2020-2031)

Figure 60. China Active Collagen Peptide Sales Market Share by Application (2020-2031)

Figure 61. China Active Collagen Peptide Revenue Market Share by Application (2020-2031)

Figure 62. Asia Active Collagen Peptide Sales Market Share by Type (2020-2031)

Figure 63. Asia Active Collagen Peptide Revenue Market Share by Type (2020-2031)

Figure 64. Asia Active Collagen Peptide Sales Market Share by Application (2020-2031)

Figure 65. Asia Active Collagen Peptide Revenue Market Share by Application (2020-2031)

Figure 66. Asia Active Collagen Peptide Revenue Share by Region (2020-2031)

Figure 67. Asia Active Collagen Peptide Sales Share by Region (2020-2031)

Figure 68. Japan Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 71. Southeast Asia Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 72. India Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 73. Australia Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Active Collagen Peptide Sales Market Share by Type (2020-2031)

Figure 75. Middle East, Africa and Latin America Active Collagen Peptide Revenue Market Share by Type (2020-2031)

Figure 76. Middle East, Africa and Latin America Active Collagen Peptide Sales Market Share by Application (2020-2031)

Figure 77. Middle East, Africa and Latin America Active Collagen Peptide Revenue Market Share by Application (2020-2031)

Figure 78. Middle East, Africa and Latin America Active Collagen Peptide Revenue Share by Country (2020-2031)

Figure 79. Middle East, Africa and Latin America Active Collagen Peptide Sales Share by Country (2020-2031)

Figure 80. Brazil Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 81. Mexico Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 82. Turkey Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 83. Israel Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 84. GCC Countries Active Collagen Peptide Revenue (2020-2031) & (US$ Million)

Figure 85. Value Chain

Figure 86. Active Collagen Peptide Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed